Edaravone 1.5mg Injection

  • Medicine name- Edastar
  • API- Edaravone
  • Pack Size- 20 ml single-dose injection
  • Strength- 1.5mg/ml
  • Manufactured By: Samarth Life Sciences Pvt Ltd
Get an Enquiry


Edaravone is indicated for the treatment of amyotrophic lateral sclerosis  (ALS).

Edaravone is a white crystalline powder with inactive ingredients  L-cysteine hydrochloride hydrate, polyvinyl alcohol, simethicone emulsion, sodium bisulfite, sorbitol, and xanthan gum.

Dosage and Side Effects

  • Edaravone: The recommended dosage is 60 mg administered as an intravenous infusion   over 60 minutes. 

  • For Edaravone: 
    • Initial treatment cycle: daily dosing for 14 days followed by a 14- day drug-free period 
    • Subsequent treatment cycles: daily dosing for 10 days out of 14- day periods, followed  by 14-day drug-free periods.

Most common adverse reactions (at least 10% of patients treated with Edaravone and greater than placebo) are contusion, gait disturbance, and headache.

Warning and Precautions

Hypersensitivity Reactions: Advise patients to seek immediate medical care. 

Sulfite Allergic Reactions: Edaravone contains sodium bisulfite, which may cause allergic type reactions, including anaphylactic symptoms and asthmatic episodes in susceptible people.


What is edaravone used for?

Edaravone is indicated for the treatment of amyotrophic lateral sclerosis  (ALS).

What is the mechanism of action of edaravone?

The mechanism by which Edaravone exerts its therapeutic effect in patients with ALS is unknown. 

Is edaravone an antioxidant?

Edaravone is a low-molecular-weight antioxidant drug targeting peroxyl radicals among many types of reactive oxygen species. Because of its amphiphilicity, it scavenges both lipid- and water-soluble peroxyl radicals by donating an electron to the radical.